% Definintive review on the EPR effect, highly cited
%  - [x] Printed
@article{maeda2000tumor,
  title={Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review},
  author={Maeda, Hiroshi and Wu, Jun and Sawa, Tomohiro and Matsumura, Yasuhiro and Hori, Katsuyoshi},
  journal={Journal of controlled release},
  volume={65},
  number={1-2},
  pages={271--284},
  year={2000},
  publisher={Elsevier}
}

% Fantastic review, highly cited
%  - [x] Printed
@article{jain2010delivering,
  title={Delivering nanomedicine to solid tumors},
  author={Jain, Rakesh K and Stylianopoulos, Triantafyllos},
  journal={Nature reviews Clinical oncology},
  volume={7},
  number={11},
  pages={653},
  year={2010},
  publisher={Nature Publishing Group}
}

% More modern review, full of drug examples
%  - [x] Printed
@article{wicki2015nanomedicine,
  title={Nanomedicine in cancer therapy: challenges, opportunities, and clinical applications},
  author={Wicki, Andreas and Witzigmann, Dominik and Balasubramanian, Vimalkumar and Huwyler, J{\"o}rg},
  journal={Journal of controlled release},
  volume={200},
  pages={138--157},
  year={2015},
  publisher={Elsevier}
}

% Lymph node collapse
%  - [ ] Printed
@article{padera2004pathology,
  title={Pathology: cancer cells compress intratumour vessels},
  author={Padera, Timothy P and Stoll, Brian R and Tooredman, Jessica B and Capen, Diane and di Tomaso, Emmanuelle and Jain, Rakesh K},
  journal={Nature},
  volume={427},
  number={6976},
  pages={695},
  year={2004},
  publisher={Nature Publishing Group}
}

% Basis for pH-responsive nanocarriers
%  - [ ] Printed
%  - [ ] Printed
@article{tannock1989acid,
  title={Acid pH in tumors and its potential for therapeutic exploitation},
  author={Tannock, Ian F and Rotin, Daniela},
  journal={Cancer research},
  volume={49},
  number={16},
  pages={4373--4384},
  year={1989},
  publisher={AACR}
}
@article{gerweck1996cellular,
  title={Cellular pH gradient in tumor versus normal tissue: potential exploitation for the treatment of cancer},
  author={Gerweck, Leo E and Seetharaman, Kala},
  journal={Cancer research},
  volume={56},
  number={6},
  pages={1194--1198},
  year={1996},
  publisher={AACR}
}

% Biological stimuli for nanocarriers, emphasis on pH stimuli
%  - [x] Printed
@article{ganta2008review,
  title={A review of stimuli-responsive nanocarriers for drug and gene delivery},
  author={Ganta, Srinivas and Devalapally, Harikrishna and Shahiwala, Aliasgar and Amiji, Mansoor},
  journal={Journal of controlled release},
  volume={126},
  number={3},
  pages={187--204},
  year={2008},
  publisher={Elsevier}
}

% Stimuli-responsive nanocarriers
%  - [ ] Printed
@article{jhaveri2014stimuli,
  title={Stimuli-sensitive nanopreparations for combination cancer therapy},
  author={Jhaveri, Aditi and Deshpande, Pranali and Torchilin, Vladimir},
  journal={Journal of controlled release},
  volume={190},
  pages={352--370},
  year={2014},
  publisher={Elsevier}
}

% Magnetically induced hyperthermia
%  - [ ] Printed
@article{scherer2002magnetofection,
  title={Magnetofection: enhancing and targeting gene delivery by magnetic force in vitro and in vivo},
  author={Scherer, Franz and Anton, M and Schillinger, U and Henke, J and Bergemann, C and Kr{\"u}ger, A and G{\"a}nsbacher, B and Plank, C},
  journal={Gene therapy},
  volume={9},
  number={2},
  pages={102},
  year={2002},
  publisher={Nature Publishing Group}
}

% Thermosensitive liposomes
%  - [ ] Printed
%  - [ ] Printed
@article{kono2001thermosensitive,
  title={Thermosensitive polymer-modified liposomes},
  author={Kono, Kenji},
  journal={Advanced drug delivery reviews},
  volume={53},
  number={3},
  pages={307--319},
  year={2001},
  publisher={Elsevier}
}
@article{ta2013thermosensitive,
  title={Thermosensitive liposomes for localized delivery and triggered release of chemotherapy},
  author={Ta, Terence and Porter, Tyrone M},
  journal={Journal of controlled release},
  volume={169},
  number={1-2},
  pages={112--125},
  year={2013},
  publisher={Elsevier}
}

% General review, covers types of nanocarriers and some examples of drugs in use
%  - [x] Printed
@article{parveen2012nanoparticles,
  title={Nanoparticles: a boon to drug delivery, therapeutics, diagnostics and imaging},
  author={Parveen, Suphiya and Misra, Ranjita and Sahoo, Sanjeeb K},
  journal={Nanomedicine: Nanotechnology, Biology and Medicine},
  volume={8},
  number={2},
  pages={147--166},
  year={2012},
  publisher={Elsevier}
}

% General review, quite long, not great
%  - [x] Printed
@article{sun2014engineered,
  title={Engineered nanoparticles for drug delivery in cancer therapy},
  author={Sun, Tianmeng and Zhang, Yu Shrike and Pang, Bo and Hyun, Dong Choon and Yang, Miaoxin and Xia, Younan},
  journal={Angewandte Chemie International Edition},
  volume={53},
  number={46},
  pages={12320--12364},
  year={2014},
  publisher={Wiley Online Library}
}

% Example of redox-responsive nanocarriers
%  - [ ] Printed
@article{saito2003drug,
  title={Drug delivery strategy utilizing conjugation via reversible disulfide linkages: role and site of cellular reducing activities},
  author={Saito, Go and Swanson, Joel A and Lee, Kyung-Dall},
  journal={Advanced drug delivery reviews},
  volume={55},
  number={2},
  pages={199--215},
  year={2003},
  publisher={Elsevier}
}

% Doxil/Caelyx
@article{harrison1995liposomal,
  title={Liposomal-entrapped doxorubicin: an active agent in AIDS-related Kaposi's sarcoma.},
  author={Harrison, M and Tomlinson, D and Stewart, S},
  journal={Journal of clinical oncology},
  volume={13},
  number={4},
  pages={914--920},
  year={1995}
}
% Abraxane
@article{desai2006increased,
  title={Increased antitumor activity, intratumor paclitaxel concentrations, and endothelial cell transport of cremophor-free, albumin-bound paclitaxel, ABI-007, compared with cremophor-based paclitaxel.},
  author={Desai, Neil and Trieu, Vuong and Yao, Zhiwen and Louie, Leslie and Ci, Sherry and Yang, Andrew and Tao, Chunlin and De, Tapas and Beals, Bridget and Dykes, Donald and others},
  journal={Clinical cancer research},
  volume={12},
  number={4},
  pages={1317--1324},
  year={2006},
  publisher={AACR}
}

% Doxil+anti-EGFR
@article{mamot2012tolerability,
  title={Tolerability, safety, pharmacokinetics, and efficacy of doxorubicin-loaded anti-EGFR immunoliposomes in advanced solid tumours: a phase 1 dose-escalation study},
  author={Mamot, Christoph and Ritschard, Reto and Wicki, Andreas and Stehle, Gregor and Dieterle, Thomas and Bubendorf, Lukas and Hilker, Christoph and Deuster, Stefanie and Herrmann, Richard and Rochlitz, Christoph},
  journal={The lancet oncology},
  volume={13},
  number={12},
  pages={1234--1241},
  year={2012},
  publisher={Elsevier}
}

% NICE on Abraxane
@online{nice2015paclitaxel,
  author={{Nationial Institute for Health and Care Excellence}},
  year=2015,
  url={https://www.nice.org.uk/guidance/ta362},
  note={[Accessed:~{2018-11-30}]}
}
